Lifecore Biomedical Inc (LFCR) — 13F Holders Deep Dive (Q2 2026)

LFCR ranks #4529 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

LFCR is a top-conviction position for Legion Partners Asset Management, LLC — at 57.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in LFCR belongs to Wynnefield Capital Inc, but the position matters far more to Legion Partners Asset Management, LLC, who has 57.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Wittenberg Investment Management, Inc. has added to its LFCR position for two straight quarters, increasing it by $1.5M to reach $1.6M today.

22nw, LP has trimmed its LFCR position for two straight quarters, cutting it by $23.0M while still holding $6.2K.

LFCR is down 0% today, but institutions show net buying of $4.0M this quarter — a divergence between today's price move and the underlying institutional flow.

LFCR reported a net loss of $32.3M over the trailing twelve months.

• Not yet profitable — net loss of $32.3M over the trailing twelve months
• Revenue grew 10.5% year over year
• Net income improved year over year, from -$38.7M to -$32.3M
• Operating cash flow was negative, using $206.0K in cash
• Current ratio of 2.84x — enough short-term assets to cover short-term liabilities
• Liabilities run 143.64x equity — a highly leveraged balance sheet worth noting